drugset / Trial / NCT01602874
Study Evaluating Tigecycline Versus Ceftriaxone In Complicated Intra-Abdominal Infections & Community Acquired Pneumonia
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The main purpose of this study is to compare the safety of tigecycline versus a ceftriaxone regimen in pediatric subjects (aged 8 to 17 years) with complicated intra-abdominal infections (cIAI) and community acquired pneumonia (CAP).
Timeline
- Start
- 2011-01
- Primary completion
- 2014-05
- Completion
- 2014-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Ceftriaxone | Other / unclassified | 35 mg/kg | Intravenous |
| Subject | Tigecycline | Small molecule | 50 mg | Intravenous |
| Comparator | Amoxicillin/clavulanate | Unknown | 40 mg/kg | Oral |
| Comparator | Clarithromycin | Small molecule | 7.5 mg/kg | Oral |
| Comparator | Metronidazole | Small molecule | 10 mg/kg | Intravenous |